Regulation of the Activity of the Human Drug Metabolizing Enzyme Arylamine N-Acetyltransferase 1: Role of Genetic and Non Genetic Factors

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|10|20|2519-2524

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.10, Iss.20, 2004-08, pp. : 2519-2524

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Human Arylamine N-Acetyltransferase 1: A Drug-Metabolizing Enzyme and a Drug Target?

By  

Current Drug Targets, Vol. 11, Iss. 6, 2010-06 ,pp. : 759-766

Bentham Science Publishers

Access to resources Recommend Favorite

Genetic Polymorphism in N-Acetyltransferase (NAT): Population Distribution of NAT1 and NAT2 Activity

By Walker Katy  

Journal of Toxicology and Environmental Health Part B: Critical Reviews, Vol. 12, Iss. 5-6, 2009-05 ,pp. : 440-472

Taylor & Francis Ltd

Access to resources Recommend Favorite

Pharmacogenomics of Arylamine N-acetyltransferase

By  

Current Pharmacogenomics, Vol. 2, Iss. 3, 2004-09 ,pp. : 219-231

Bentham Science Publishers

Access to resources Recommend Favorite

Structure and Regulation of the Drug-Metabolizing Enzymes Arylamine N-acetyltransferases

By  

Current Medicinal Chemistry, Vol. 12, Iss. 3, 2005-02 ,pp. : 311-318

Bentham Science Publishers

Access to resources Recommend Favorite

Prediction of Human Drug Metabolizing Enzyme Induction

By  

Current Drug Metabolism, Vol. 4, Iss. 5, 2003-10 ,pp. : 381-391

Bentham Science Publishers

Access to resources Recommend Favorite